Literature DB >> 30106105

Identification of genes and genetic networks associated with BAG3‑dependent cell proliferation and cell survival in human cervical cancer HeLa cells.

Yukihiro Furusawa1, Tatsuya Yunoki2, Tetsushi Hirano3, Satsuki Minagawa3, Hironori Izumi4, Hisashi Mori4, Atsushi Hayashi2, Yoshiaki Tabuchi3.   

Abstract

Bcl‑2‑associated athanogene (BAG) 3, is a member of the BAG protein family and a known co‑chaperone of heat shock protein (HSP) 70. BAG3 serves a role in regulating a variety of cellular functions, including cell growth, proliferation and cell death including apoptosis. BAG3 is a stress‑inducible protein, however the constitutive expression level of BAG3 is increased in cancer cells compared with healthy cells. Recent proteomics technology combined with bioinformatics has revealed that BAG3 participates in an interactome with a number of proteins other than its typical partner HSP70. The functional types represented in the interactome included nucleic acid binding proteins and transcription factors, as well as chaperones, which indicated that overexpression of BAG3 may contribute to proliferation and cell survival through the alteration of gene transcription. While an increasing number of studies have addressed the function of BAG3 as a co‑chaperone protein, BAG3‑dependent alteration of gene transcription has not been studied extensively. The present study established two BAG3 knockout human cervical cancer HeLa cell clones and addressed the role of BAG3 in cell proliferation and survival through gene transcription, using DNA microarray‑based transcriptome analysis and bioinformatics. The present study also identified two genetic networks associated with 'cellular growth and proliferation' and 'cell death and survival', which are dysregulated in the absence of BAG3, and may therefore be linked to BAG3 overexpression in cancer. These findings provide a molecular basis for understanding of BAG3‑dependent cell proliferation and survival from the aspect of alteration of gene expression.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30106105     DOI: 10.3892/mmr.2018.9383

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

Review 1.  The role of BAG3 in health and disease: A "Magic BAG of Tricks".

Authors:  Heng Lin; Shon A Koren; Gregor Cvetojevic; Peter Girardi; Gail V W Johnson
Journal:  J Cell Biochem       Date:  2021-05-14       Impact factor: 4.480

2.  Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro.

Authors:  Feifang Zhang; Qun Zhou
Journal:  Mol Med Rep       Date:  2018-09-26       Impact factor: 2.952

Review 3.  An emerging role for BAG3 in gynaecological malignancies.

Authors:  Margot De Marco; Antonia Falco; Roberta Iaccarino; Antonio Raffone; Antonio Mollo; Maurizio Guida; Alessandra Rosati; Massimiliano Chetta; Giovanni Genovese; Francesco De Caro; Mario Capunzo; Maria Caterina Turco; Vladimir N Uversky; Liberato Marzullo
Journal:  Br J Cancer       Date:  2021-06-07       Impact factor: 9.075

4.  HIKESHI silencing can enhance mild hyperthermia sensitivity in human oral squamous cell carcinoma HSC‑3 cells.

Authors:  Yoshiaki Tabuchi; Keita Maekawa; Misako Torigoe; Yukihiro Furusawa; Tetsushi Hirano; Satsuki Minagawa; Tatsuya Yunoki; Atsushi Hayashi
Journal:  Int J Mol Med       Date:  2020-04-28       Impact factor: 4.101

5.  Bioinformatics analysis of the microRNA-mRNA network in sebaceous gland carcinoma of the eyelid.

Authors:  Tetsushi Hirano; Tatsuya Yunoki; Yukihiro Furusawa; Yoshiaki Tabuchi; Atsushi Hayashi
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

6.  BAG3 Proteomic Signature under Proteostasis Stress.

Authors:  Christof Hiebel; Elisabeth Stürner; Meike Hoffmeister; Georg Tascher; Mario Schwarz; Heike Nagel; Christian Behrends; Christian Münch; Christian Behl
Journal:  Cells       Date:  2020-11-04       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.